Refresh

Suven Pharmaceuticals Ltd. - Research Center

543064 SUVENPHAR Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

1,024.99 1,330.08 1,320.22 1,009.72 833.79
Expenses

Material consumed

305.07 402.36 401.55 303.70 230.14

Manufacturing expenses

124.97 168.93 170.74 120.98 104.80

Personnel expenses

126.88 100.84 100.48 87.29 73.72

Selling expenses

- - - - -

Adminstrative expenses

58.17 74.87 67.46 57.23 39.98

Expenses capitalised

- - - - -

Cost of sales

615.09 747.00 740.23 569.20 448.64

Operating profit

409.90 583.08 579.99 440.52 385.15

Other recurring income

55.09 44.55 187.79 14.24 18.12

Adjusted PBDIT

464.99 627.63 767.78 454.76 403.26

Financial expenses

7.43 5.39 6.23 9.14 21.81

Depreciation

48.79 42.84 39.10 31.64 23.86

Other write offs

- - - - -

Adjusted PBT

408.77 579.39 722.45 413.98 357.59

Tax charges

103.96 146.79 164.35 105.33 87.51

Adjusted PAT

304.82 432.60 558.10 308.65 270.08

Non recurring items

-0.30 -0.35 -0.76 - -0.82

Other non cash adjustments

- - - - -

Reported net profit

304.52 432.25 557.34 308.65 269.26

Earnigs before appropriation

1,794.59 1,708.64 1,393.21 877.17 660.25

Equity dividend

- 203.65 101.83 25.46 50.56

Preference dividend

- - - - -

Dividend tax

- - - - 13.08

Retained earnings

1,794.59 1,504.99 1,291.39 851.71 596.60
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com